Paper Details

  1. Home
  2. Paper Details

Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype.

Author: BernsteinJonathan A, EngelMichael, GoldsteinStanley, HamelmannEckard, MansfieldLyndon, SzeflerStanley J, VogelbergChristian, Zaremba-PechmannLiliana

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Tiotropium, used as an add-on therapy for children with asthma, improved lung function regardless of blood eosinophil counts or serum IgE levels. These findings suggest that tiotropium may be beneficial for a wide range of asthma patients.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Tiotropium add-on therapy has demonstrated efficacy and safety in 6- to 17-year-olds with symptomatic asthma despite treatment with inhaled corticosteroids (ICSs), with or without additional controllers. Pediatric patients often have a significant allergic component to their asthma. OBJ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jaip.2019.03.019

データ提供：米国国立医学図書館（NLM）

Tiotropium for Asthma: Effective Regardless of Allergic Response

This research focuses on the efficacy of tiotropium, a medication used to treat asthma. The study examined whether the effectiveness of tiotropium in children and adolescents with asthma is influenced by their allergic response, specifically their levels of IgE and blood eosinophils. These factors are often associated with allergic asthma. The results of the study showed that tiotropium was effective in improving lung function in children and adolescents with asthma, regardless of their allergic response. It's like a desert oasis offering relief to travelers, regardless of their journey's origin.

Understanding Asthma

The research suggests that tiotropium can be a valuable treatment option for a wide range of asthma patients, even those with a strong allergic component. This is a significant finding that could help doctors to personalize asthma treatment plans.

Living Well with Asthma

This study is a reminder that there are effective treatments available for asthma, regardless of the specific type or severity of the condition. It encourages individuals with asthma to work closely with their doctor to develop a treatment plan that meets their individual needs. This research is like a guidebook for navigating the desert of asthma, providing valuable information for those seeking relief.

Dr.Camel's Conclusion

Tiotropium, like a trusty camel navigating a desert landscape, provides relief for asthma sufferers, regardless of their allergic response. This research offers a valuable insight into asthma treatment and highlights the importance of personalized care.

Date :
  1. Date Completed 2020-10-05
  2. Date Revised 2020-10-05
Further Info :

Pubmed ID

30922990

DOI: Digital Object Identifier

10.1016/j.jaip.2019.03.019

Related Literature

Article Analysis
・Effective treatment of asthma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.